Kasper Møller

Chief Tech/Sci/R&D Officer at MOLMED S.P.A.

Health Technology

Consumer Services

Profile

Kasper Møller is currently the Chief Technical Officer at AGC Biologics SpA since 2019.
He is also the Chief Technology Officer at AGC Biologics A since 2006.
Previously, he worked as a Faculty Member at the Technical University of Denmark.
Dr. Møller holds a doctorate degree from the Technical University of Denmark, which he obtained in 2001.
He also has a graduate degree from Washington University School of Medicine.

Kasper Møller active positions

Companies	Position	Start
MOLMED S.P.A.	Chief Tech/Sci/R&D Officer	2019-05-31
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.	Chief Tech/Sci/R&D Officer	2019-06-03

All active positions of Kasper Møller

Former positions of Kasper Møller

Companies	Position	End
Technical University of Denmark	Corporate Officer/Principal	-

See the detail of Kasper Møller's experience

Training of Kasper Møller

Technical University of Denmark	Doctorate Degree
Washington University School of Medicine	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kasper Møller's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
AGC Biologics SpA AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy.	Health Technology
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.	Health Technology